BioXcel Therapeutics (BTAI) P/S (2022 - 2026)
BioXcel Therapeutics (BTAI) P/S from Sep 30, 2022 to Jun 12, 2026. The TTM BioXcel Therapeutics (BTAI) P/S is 44.73. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/S
Annual P/S change of BioXcel Therapeutics (BTAI)
| Year | P/S | Change |
|---|---|---|
| 2026 | 44.73 | -18.61% |
| 2025 | 54.96 | +569.34% |
| 2024 | 8.21 | -97.81% |
| 2023 | 374.11 | -98.46% |
| 2022 | 24.32K | N/A |
Comparison BioXcel Therapeutics (BTAI) P/S with competitors
BioXcel Therapeutics (BTAI) P/S is 44.73.